Loading …

Caelium is a biopharmaceutical research and development company founded by internationally recognized leaders in brain imaging, radiology, and neurodegenerative disease research. The company was built on decades of work studying how brain degeneration unfolds across conditions such as Alzheimer’s and Traumatic Brain Injury.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.